Improvement of different vaccine delivery systems for cancer therapy A Bolhassani, S Safaiyan, S Rafati Molecular cancer 10, 1-20, 2011 | 384 | 2011 |
Leishmaniasis vaccine candidates for development: a global overview A Khamesipour, S Rafati, N Davoudi, F Maboudi, F Modabber Indian Journal of Medical Research 123 (3), 423, 2006 | 270 | 2006 |
Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis A Salhi, V Rodrigues, F Santoro, H Dessein, A Romano, LR Castellano, ... The Journal of Immunology 180 (9), 6139-6148, 2008 | 204 | 2008 |
Heat-shock proteins as powerful weapons in vaccine development A Bolhassani, S Rafati Expert review of vaccines 7 (8), 1185-1199, 2008 | 184 | 2008 |
Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum S Rafati, A Nakhaee, T Taheri, Y Taslimi, H Darabi, D Eravani, S Sanos, ... Vaccine 23 (28), 3716-3725, 2005 | 172 | 2005 |
A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major S Rafati, AH Salmanian, T Taheri, M Vafa, N Fasel Vaccine 19 (25-26), 3369-3375, 2001 | 141 | 2001 |
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis A Mizbani, T Taheri, F Zahedifard, Y Taslimi, H Azizi, K Azadmanesh, ... Vaccine 28 (1), 53-62, 2009 | 126 | 2009 |
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis S Rafati, F Zahedifard, F Nazgouee Vaccine 24 (12), 2169-2175, 2006 | 114 | 2006 |
CD8+ T Cells in Leishmania Infections: Friends or Foes? S Stäger, S Rafati Frontiers in immunology 3, 5, 2012 | 108 | 2012 |
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies A Bolhassani, T Taheri, Y Taslimi, S Zamanilui, F Zahedifard, N Seyed, ... Experimental parasitology 127 (3), 637-645, 2011 | 108 | 2011 |
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice M Golkar, MA Shokrgozar, S Rafati, K Musset, M Assmar, R Sadaie, ... Vaccine 25 (21), 4301-4311, 2007 | 104 | 2007 |
Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157: H7 J Amani, AH Salmanian, S Rafati, SL Mousavi Vaccine 28 (42), 6923-6929, 2010 | 97 | 2010 |
Leishmaniasis and various immunotherapeutic approaches Y Taslimi, F Zahedifard, S Rafati Parasitology 145 (4), 497-507, 2018 | 95 | 2018 |
Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies A Bolhassani, F Zahedifard, M Taghikhani, S Rafati Vaccine 26 (26), 3362-3370, 2008 | 93 | 2008 |
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection D Doroud, F Zahedifard, A Vatanara, AR Najafabadi, Y Taslimi, ... Journal of controlled release 153 (2), 154-162, 2011 | 92 | 2011 |
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis A Zadeh-Vakili, T Taheri, Y Taslimi, F Doustdari, AH Salmanian, S Rafati Vaccine 22 (15-16), 1930-1940, 2004 | 81 | 2004 |
Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157: H7 in mice J Amani, SL Mousavi, S Rafati, AH Salmanian Plant science 180 (4), 620-627, 2011 | 80 | 2011 |
Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ... PLoS neglected tropical diseases 8 (3), e2751, 2014 | 79 | 2014 |
Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, ... PLoS neglected tropical diseases 7 (4), e2174, 2013 | 75 | 2013 |
Cationic solid lipid nanoparticles loaded by cystein proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations D Doroud, A Vatanara, F Zahedifard, E Gholami, R Vahabpour, ... Journal of Pharmacy & Pharmaceutical Sciences 13 (3), 320-335, 2010 | 74 | 2010 |